Ubs Group Ag Beyond Spring Inc. Transaction History
Ubs Group Ag
- $611 Billion
- Q3 2025
A detailed history of Ubs Group Ag transactions in Beyond Spring Inc. stock. As of the latest transaction made, Ubs Group Ag holds 1,338 shares of BYSI stock, worth $2,863. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,338
Previous 6,951
80.75%
Holding current value
$2,863
Previous $16,000
87.5%
% of portfolio
0.0%
Previous 0.0%
Shares
32 transactions
Others Institutions Holding BYSI
# of Institutions
22Shares Held
5.5MCall Options Held
270KPut Options Held
0-
Decheng Capital LLC Menlo Park, CA4.29MShares$9.17 Million1.35% of portfolio
-
Vanguard Group Inc Valley Forge, PA547KShares$1.17 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA315KShares$675,1350.0% of portfolio
-
Black Rock Inc. New York, NY215KShares$460,8590.0% of portfolio
-
Northern Trust Corp Chicago, IL70.8KShares$151,4640.0% of portfolio
About BeyondSpring Inc.
- Ticker BYSI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,928,900
- Market Cap $83.3M
- Description
- BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and...